Previsions show a CAGR of 6.9% for the biotech market in Healthcare reaching the 25% of global market for prescription drugs; industrial biotech is expected to increase to €228bn and the agricultural biotechnology market is expected reach a value of $12bn
Such promising figures require capacities to accelerate the entrance of new products into market
Who we are?
We are a biotechnology customer-centric company with strong background, providing solutions in health and food sectors:
We provide services helping our clients with a high level of flexibility, cost oriented, open communication, reliability and confidentiality
But we can also provide products thanks to our own antigen display technology with a strong potential to boost and direct specific immune responses, humoral or cellular depending on the construct